Fluoroestradiol F 18

F-18氟代雌二醇

Report date: 2025/11/25 15:52:57
NME

Base Information

Drug NameFluoroestradiol F 18
Drug Alias Name18F-fluoroestradiolFluorine-18-16alpha-fluoroestradiol[18-F]-16alpha-fluoroestradiol16alpha-fluoroestradiol-[18F][18-F] 16alpha-fluoroestradiol +[10] 
ClassificationRadiation-emitting products > Radioactive diagnostic agentSmall molecules > Heterocyclic drugsRadiation-emitting products > Nuclides > Fluorine > 18F +[5] 
Mechanisms of ActionIonising radiation emittersPositron-emission tomography enhancersEstrogen receptors agonists
TargetsEstrogen receptors
Therapy Area/IndicationsMetastatic breast cancerDiagnostic agentsEndometriosis +[8] 
Global Approved IndicationsDiagnostic agentsBreast Neoplasms
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2020/05/20
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesWashington UniversityNational Cancer InstituteZionexa
China Registration ClassN/A

Develop Information

Active CompaniesGe HealthcareNational Cancer InstituteUniversity Of North Carolina At Chapel Hill +[4] 
Inactive CompaniesUtah State UniversityUniversity of Texas Southwestern Medical CenterUniversity Of Washington
Active IndicationsMetastatic breast cancerDiagnostic agentsEndometriosis +[4] 
Inactive IndicationsCarcinoma, LobularAdenomatous Polyposis ColiFibromatosis, Aggressive +[4] 

Other Information

ATC CodeV09IX11
Related LinksN/A